Position in XGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$534,252
+$189,573 QoQ
Shares Held
114,893
0.0% QoQ
Ownership
0.474%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#18
of 57 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in XGN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026PERCEPTIVE ADVISORS LLC holds $89,317,840 across 9 Diagnostics & Research names. XGN ranks #8 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRL |
Charles River Laboratories International, Inc.
|
140,000 | $31,750,600 | |
| 2 | DHR |
Danaher Corp /De/
|
130,000 | $24,762,400 | |
| 3 | BLLN |
BillionToOne, Inc.
|
86,812 | $10,415,703 | |
| 4 | NTRA |
Natera, Inc.
|
34,689 | $9,416,329 | |
| 5 | GH |
Guardant Health, Inc.
|
41,327 | $6,200,289 | |
| 6 | TWST |
Twist Bioscience Corp
|
36,812 | $3,787,218 | |
| 7 | BDSX |
Biodesix Inc
|
108,694 | $2,451,049 | |
| 8 | XGN |
Exagen Inc.
This page
|
114,893 | $534,252 |
All Filings in XGN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $534,252 | 114,893 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $344,679 | 114,893 | Shares | Sole | 2026-05-29 | |
| No filing history on record for this holder in this stock. | ||||||